Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.

Szmulewicz, Alejandro; Samamé, Cecilia; Caravotta, Pablo; Martino, Diego J; Igoa, Ana; Hidalgo-Mazzei, Diego; Colom, Francesc; Strejilevich, Sergio A.

Afiliação

Szmulewicz A; Bipolar Disorder Program, Neurosciences Institute, Favaloro University, Buenos Aires, Argentina. alejandroszm@gmail.com.
Samamé C; Hospital de Emergencias Psiquiátricas Torcuato de Alvear (HEPTA), Buenos Aires, Argentina. alejandroszm@gmail.com.
Caravotta P; Bipolar Disorder Program, Neurosciences Institute, Favaloro University, Buenos Aires, Argentina. ceciliasamame@gmail.com.
Martino DJ; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina. ceciliasamame@gmail.com.
Igoa A; Bipolar Disorder Program, Neurosciences Institute, Favaloro University, Buenos Aires, Argentina. pablocaravotta@gmail.com.
Hidalgo-Mazzei D; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina. pablocaravotta@gmail.com.
Colom F; Bipolar Disorder Program, Neurosciences Institute, Favaloro University, Buenos Aires, Argentina. diejmartino@gmail.com.
Strejilevich SA; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina. diejmartino@gmail.com.

Int J Bipolar Disord ; 4(1): 6, 2016 Dec.

Article em En | MEDLINE | ID: mdl-26879750